|
SAR1A expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.53239999969956E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.91119999999723E-05 |
| Normal-vs-Stage2 |
3.455300E-03 |
| Normal-vs-Stage3 |
2.2837999999914E-05 |
| Normal-vs-Stage4 |
3.75280000000089E-05 |
| Stage1-vs-Stage2 |
6.568400E-01 |
| Stage1-vs-Stage3 |
2.129200E-01 |
| Stage1-vs-Stage4 |
3.458600E-01 |
| Stage2-vs-Stage3 |
6.712400E-01 |
| Stage2-vs-Stage4 |
8.674400E-01 |
| Stage3-vs-Stage4 |
7.210800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.7001999999069E-07 |
| Normal-vs-AfricanAmerican |
1.10610000048084E-07 |
| Normal-vs-Asian |
5.460400E-02 |
| Caucasian-vs-AfricanAmerican |
4.676100E-02 |
| Caucasian-vs-Asian |
9.278200E-01 |
| AfricanAmerican-vs-Asian |
5.005200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.65750000286269E-08 |
| Normal-vs-Female |
9.002200E-04 |
| Male-vs-Female |
1.367940E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.061600E-02 |
| Normal-vs-Age(41-60Yrs) |
1.70127999999936E-05 |
| Normal-vs-Age(61-80Yrs) |
4.12220000023389E-07 |
| Normal-vs-Age(81-100Yrs) |
4.915000E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.209800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.565200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.128200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.744000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.929800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.067800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.207200E-01 |
| Normal-vs-Grade 2 |
1.835540E-03 |
| Normal-vs-Grade 3 |
1.71279990190953E-10 |
| Normal-vs-Grade 4 |
5.62840000000175E-05 |
| Grade 1-vs-Grade 2 |
2.218600E-01 |
| Grade 1-vs-Grade 3 |
1.324590E-03 |
| Grade 1-vs-Grade 4 |
2.704200E-02 |
| Grade 2-vs-Grade 3 |
4.641700E-04 |
| Grade 2-vs-Grade 4 |
1.267840E-01 |
| Grade 3-vs-Grade 4 |
2.123800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.351500E-04 |
| Normal-vs-ccB subtype |
2.14060000000016E-05 |
| ccA subtype-vs-ccB subtype |
1.632010E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.182910E-04 |
| Normal-vs-N1 |
4.478000E-01 |
| N0-vs-N1 |
4.373200E-01 |
|
|
